Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Redhill Biopharma beat estimated earnings by 84.85%, reporting an EPS of $-0.05 versus an estimate of $-0.33.

Revenue was up $610.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.29 which was followed by a 6.85% drop in the share price the next day.

Here's a look at Redhill Biopharma's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.